next generation precision oncology

The treatment options under consideration,
ranked on living human tissue,
before you choose one

cResponse™ tests multiple therapies simultaneously on a patient's own intact tumor tissue, producing a ranked, personalized functional answer, not a population statistic.

ISO 15189:2022

CE marked,
ISO 15189:2022 Medical Laboratories

90%+ Accuracy

Prediction accuracy, PPV & NPV
against clinical outcomes

All Solid Tumors

Applicable to
all solid tumors

All Therapy Classes

Applicable to all therapy
classes and combinations

One platform, four audiences
Functional testing serves a different decision and provides unique value to four possible stake-holders.
for patients

Know what actually works, before you start.

A test on your own tumor tissue shows which treatments are likely to work, and which aren't worth the side effects.

Learn more →
for clinicians

Less trial and error.

A ranked, functional answer for your patient's own tumor, to identify the options with the strongest response.

Explore clinical services →
for payers

Direct spend to treatments more likely to work.

Objective, functional evidence to support or redirect high-cost, high-variability treatment decisions.

Explore payer solutions →
for pharma

De-risk your pipeline

Human-validated functional data optimizing lead selection, indication finding, patient stratification, and in-licensing diligence.

Explore pharma services →

Ready to unlock precision oncology?